Daniela S Krause

Title: Daniela S Krause: Innovator in Haematological Treatments

Introduction

Daniela S Krause is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of haematology through her innovative research and development of therapeutic compounds. Her work focuses on improving treatment outcomes for patients with haematological complications.

Latest Patents

Krause holds a patent for "Periostin compounds for the treatment of haematological complications." This invention pertains to the use of periostin compounds in the prevention and treatment of adverse events from therapy or haematological diseases. The therapeutic developed enhances haematopoiesis in patients and supports haematopoietic stem cell (HSC) transplantation. By administering periostin compounds to patients or stem cell donors, or by contacting HSC directly with these compounds, the preparation of transplant HSC can be improved. The invention includes periostin-derived compounds such as polypeptides, peptides, nucleic acids, and other agents used in therapeutic applications.

Career Highlights

Throughout her career, Daniela S Krause has worked with notable institutions, including the Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus and Universitätsmedizin der Johannes Gutenberg-Universität Mainz. Her research has been pivotal in advancing the understanding and treatment of haematological conditions.

Collaborations

Krause has collaborated with various professionals in her field, including Divij Verma. These collaborations have contributed to her innovative research and the development of her patented compounds.

Conclusion

Daniela S Krause is a key figure in the field of haematology, with her innovative work on periostin compounds paving the way for improved treatments for patients with haematological complications. Her contributions continue to impact the medical community positively.